DrugPatentWatch Database Updates: New Patent Additions
✉ Email this page to a colleague
DrugPatentWatch Database Updates: New Patent Additions
| Applicant | Tradename | Generic Name | Dosage | NDA | Number | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Requested | Patent Expiration | Date Submitted | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms | XYREM | sodium oxybate | SOLUTION | 021196 | 001 | Jul 17, 2002 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | U-1110 | METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING A COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION | ||||
| Jazz Pharms | XYREM | sodium oxybate | SOLUTION | 021196 | 001 | Jul 17, 2002 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||||
| Beigene | BRUKINSA | zanubrutinib | CAPSULE | 213217 | 001 | Nov 14, 2019 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | 2023-11-02 | U-3875 | TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (FL) RECEIVING A MODERATE CYP3A INDUCER, IN COMBINATION WITH OBINUTUZUMAB, AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Number | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Requested | >Patent Expiration | >Date Submitted | >Usecode | >Patented / Exclusive Use |
